Center for Rare Neurological Diseases

Norcross, Georgia 30093

0 studies enrolling now · 10 studies all time

What they study most

15q Duplication Syndrome, CDKL5 Deficiency Disease, Cyclin-Dependent Kinase-Like 5 Deficiency Disorder, Dravet Syndrome, Dravet Syndrome (DS), Epilepsy, Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS), Lennox-Gastaut Syndrome, Lennox-Gastaut Syndrome (LGS), Refractory Infantile Spasms, Rett Syndrome

Studies at this site

• A Study of Soticlestat in Adults and Children With Rare Epilepsies — Stopped early
• Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy — Completed
• Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder — Running, not enrolling
• A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients — Stopped early
• Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies — Completed
• A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY) — Completed
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies — Completed
• Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern — Completed
• Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin — Status unconfirmed
• Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) — Stopped early